| Literature DB >> 35352966 |
Wei Li Adeline Koay1,2, Jiayang Xiao3, Marinella Temprosa3, Lindsey P Happ4, Anne K Monroe4, Amanda D Castel4, Natella Y Rakhmanina1,2,5.
Abstract
This study explored virological outcomes of two-drug (2DRs) and three-drug (3DRs) antiretroviral regimens in adults with HIV in the DC Cohort. We analyzed 310 treatment-experienced adults with sustained HIV RNA ≤50 copies/mL at baseline, 53 of whom switched to 2DRs and 257 continued 3DRs. Adults on 2DRs and 3DRs had similar demographics (median age 53.3 years, 76.8% cisgender male, 76.1% Black). Adults on 2DRs had more participants with ≥2 comorbidities (62.3% vs. 42.8%, p = .019), had a longer time since HIV diagnosis (median years 20.4 vs. 13.2, p = .017), and received the regimen of interest for a shorter duration (median years 1.3 vs. 3.3, p < .001) compared with adults on 3DRs. Adults receiving 2DRs had a higher, although nonsignificant, risk for virological failure (two consecutive HIV RNA ≥50 copies/mL) at 24 months follow-up than adults on 3DRs (6.7% vs. 1.7%, respectively; p = .10). Future analysis of the effectiveness of 2DRs is needed.Entities:
Keywords: HIV; antiretroviral therapy; dual therapy; regimen simplification; two-drug regimen
Mesh：
Substances：
Year: 2022 PMID： 35352966 PMCID： PMC9225828 DOI： 10.1089/aid.2021.0202
Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN： 0889-2229 Impact factor: 1.723